UKE Names Pioneering Cardiac Surgeon as New Heart Surgery Chief
UKE Names Pioneering Cardiac Surgeon as New Heart Surgery Chief
UKE Names Pioneering Cardiac Surgeon as New Heart Surgery Chief
The University Hospital Hamburg-Eppendorf (UKE) has appointed Prof. Dr. Evaldas Girdauskas as the new head of its clinic for heart and vascular surgery. He takes over from Prof. Dr. Dr. Hermann Reichenspurner, who led the department for years and will now serve in an advisory role. Girdauskas brings a strong focus on minimally invasive techniques and advanced surgical innovation to the position.
Prof. Girdauskas arrives at the UKE with a distinguished career in cardiac surgery. He has performed and led robot-assisted procedures, including aortic and mitral valve operations, at renowned institutions like Leipzig Heart Center and Toronto General Hospital. His expertise spans complex interventions, with a particular emphasis on faster recovery through minimally invasive methods and ERAS (Enhanced Recovery After Surgery) protocols.
His research background is equally impressive. With over 800 scientific publications, Girdauskas has earned national and international recognition for his work in transplantation medicine and cardiovascular care. His studies concentrate on population-based and biomarker-driven approaches, aiming to refine personalised treatment strategies for heart patients. At the UKE, he plans to build a cutting-edge heart surgery programme. This will include the full range of modern cardiac procedures, with a special push for robot-assisted techniques. The goal is to offer tailored, patient-focused care while maintaining the department's reputation for excellence in complex surgeries. Prof. Reichenspurner, the outgoing head, leaves a lasting legacy in heart-lung transplantation and minimally invasive surgery. His contributions helped shape the UKE's cardiac department into a leading centre for advanced cardiovascular medicine.
Prof. Girdauskas will now lead the UKE's heart and vascular surgery team, introducing new surgical technologies and personalised treatment plans. His appointment follows a long career marked by innovation in cardiac care. Meanwhile, Prof. Reichenspurner remains involved as an advisor, ensuring continuity in the department's strategic development.
Sinus bradycardia: When a slow heartbeat signals trouble or health
A heartbeat below 60 isn't always dangerous—unless it hides something worse. Discover the warning signs and how to protect your heart.
New Immunotoxin Treatment Shows Promise Against Liver Fibrosis in Mice
Scientists may have found a game-changer for liver disease. By attacking scar-forming cells, this therapy could redefine fibrosis treatment.
Portugal to Overhaul Pay for Locum Doctors in Emergency Shifts
A game-changer for overworked physicians? Portugal's new decree rewards emergency shift doctors—but unions are still negotiating the fine print. Will it ease hospital staffing crises?
Five Silent Warning Signs Your Liver May Be in Trouble
Your liver might be struggling long before you notice. From restless nights to mysterious weight changes, these red flags could save your health.